Related Experiment Video
Updated: Feb 8, 2026

Isolation of Small Noncoding RNAs from Human Serum
Published on: June 19, 2014
Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
Po-Li Wei1,2,3,4, Long-Teng Lee5, Li-Ming Tseng6
1Department of Surgery, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Abstract:
Immunomagnetic reduction (IMR) is a method to assay biomolecules by utilizing antibody functionalized magnetic nanoparticles. For clinical validation, important analytic performances of assaying carcinoembryonic antigen (CEA) using IMR are characterized. Furthermore, IMR is applied to assay carcinoembryonic antigen (CEA) in human serum for clinical validation. A total of 118 healthy controls and 79 patients with colorectal cancer (CRC) are recruited in this study. For comparison, assays using chemiluminometric immunoassay (CLIA) are also done for quantizing CEA in these serum samples. The results reveal a high correlation in terms of serum CEA concentration detected via IMR and CLIA is found (r = 0.963). However, IMR shows higher clinical sensitivity and specificity than those of CLIA. Moreover, the rate of false positives for smoking subjects is clearly reduced through the use of IMR. All the results demonstrate IMR is a promising alternative assay for serum CEA to diagnose CRC.
Related Concept Videos
Reliability and Validity
Oxidation-Reduction Reactions
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Oxymercuration-Reduction of Alkenes
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...

